Background and Purpose: Cerebral large vessel occlusion (LVO) in acute ischemic stroke (AIS) may be complete (CLVO) or incomplete (ILVO). The influence of ILVO on clinical outcome after mechanical thrombectomy (MT) remains unclear. We investigated primarily the clinical outcome in patients with AIS due to ILVO or CLVO. Methods: Five hundred three consecutive AIS patients with LVO treated with stent-retriever or direct aspiration-based MT between 2010 and 2016 were analyzed. The primary endpoint was favorable clinical outcome (modified Rankin Scale ≤2) at 90 days; secondary endpoints were periprocedural parameters. Results: Forty-nine patients (11.3%) with a median National Institutes of Health Stroke Scale (NIHSS) of 11 presented with ILVO and the remainder presented with CLVO and median NIHSS of 15 (p < 0.001). The median groin puncture-to-reperfusion time was 30 vs. 67 min, respectively (p < 0.001). Successful reperfusion was reached in 47 out of 49 ILVO (95.9%) vs. 298 out of 381 CLVO (78.2%; p < 0.005) with less retrieval maneuvers (1.7 ± 2.2 vs. 3.0 ± 2.5; p < 0.001). The favorable outcome at 90 days was 81% in patients with ILVO vs. 29.1% in CLVO (p < 0.001); respective all-cause mortality rates were 6.4 vs. 28.5% (p < 0.001). Periprocedural complications (6.9%) occurred exclusively in CLVO patients (p < 0.05). ILVO was associated with favorable clinical outcome independent of age and NIHSS in multivariate logistic regression both in the anterior (OR 3.6; 95% CI 1.8-6.9; p < 0.001) and posterior circulation (OR 3.5; 95% CI 1.8-6.9; p < 0.001). Conclusions: AIS due to ILVO is frequent and is associated with a nearly threefold higher chance of favorable clinical outcome at 90 days, independent of age and initial NIHSS compared to CLVO.

Keywords:
Acute ischemic stroke, Incomplete large vessel occlusion, Mechanical thrombectomy
1.
Rha JH, Saver JL: The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967-973.
2.
Spiotta AM, Vargas J, Turner R, Chaudry MI, Battenhouse H, Turk AS: The golden hour of stroke intervention: effect of thrombectomy procedural time in acute ischemic stroke on outcome. J Neurointerv Surg 2014;6:511-516.
3.
Guedin P, Larcher A, Decroix JP, Labreuche J, Dreyfus JF, Evrard S, et al: Prior IV thrombolysis facilitates mechanical thrombectomy in acute ischemic stroke. J Stroke Cerebrovasc Dis 2015;24:952-957.
4.
Castonguay AC, Zaidat OO, Novakovic R, Nguyen TN, Taqi MA, Gupta R, et al: Influence of age on clinical and revascularization outcomes in the North American solitaire stent-retriever acute stroke registry. Stroke 2014;45:3631-3636.
5.
Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, et al: Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke 2008;39:2257-2263.
6.
Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O: The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 2011;42:1775-1777.
7.
Liebeskind DS, Tomsick TA, Foster LD, Yeatts SD, Carrozzella J, Demchuk AM, et al: Collaterals at angiography and outcomes in the interventional management of stroke (IMS) III trial. Stroke 2014;45:759-764.
8.
Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al: Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723-1731.
9.
Wahlgren N, Moreira T, Michel P, Steiner T, Jansen O, Cognard C, et al: Mechanical thrombectomy in acute ischemic stroke: consensus statement by ESO-Karolinska stroke update 2014/2015, supported by ESO, ESMINT, ESNR and EAN. Int J Stroke 2016;11:134-147.
10.
Khatri P, Neff J, Broderick JP, Khoury JC, Carrozzella J, Tomsick T, et al: Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;36:2400-2403.
11.
Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL, et al: Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke 2013;44:2650-2663.
12.
Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.
13.
Delgado Almandoz JE, Kayan Y, Young ML, Fease JL, Scholz JM, Milner AM, et al: Comparison of clinical outcomes in patients with acute ischemic strokes treated with mechanical thrombectomy using either Solumbra or ADAPT techniques. J Neurointerv Surg 2016;8:1123-1128.
14.
Maus V, Behme D, Kabbasch C, Borggrefe J, Tsogkas I, Nikoubashman O, et al: Maximizing first-pass complete reperfusion with SAVE. Clinl Neuroradiol 2017, DOI: 10.1007/s00062-017-0566-z [Epub ahead of print].
15.
Turk AS, Frei D, Fiorella D, Mocco J, Baxter B, Siddiqui A, et al: ADAPT FAST study: a direct aspiration first pass technique for acute stroke thrombectomy. J Neurointerv Surg 2014;6:260-264.
16.
Kabbasch C, Mohlenbruch M, Stampfl S, Mpotsaris A, Behme D, Liebig T: First-line lesional aspiration in acute stroke thrombectomy using a novel intermediate catheter: initial experiences with the SOFIA. Interv Neuroradiol 2016;22:333-339.
17.
Kowoll A, Weber A, Mpotsaris A, Behme D, Weber W: Direct aspiration first pass technique for the treatment of acute ischemic stroke: initial experience at a European stroke center. J Neurointerv Surg 2016;8:230-234.
18.
Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al: A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11-20.
19.
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al: Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019-1030.
20.
Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al: Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015;372:1009-1018.
21.
Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al: Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015;372:2296-2306.
22.
Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al: Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015;372:2285-2295.
23.
Vanacker P, Lambrou D, Eskandari A, Maeder P, Meuli R, Ntaios G, et al: Improving prediction of recanalization in acute large-vessel occlusive stroke. J Thromb Haemost 2014;12:814-821.
24.
Humphries W, Hoit D, Doss VT, Elijovich L, Frei D, Loy D, et al: Distal aspiration with retrievable stent assisted thrombectomy for the treatment of acute ischemic stroke. J Neurointerv Surg 2015;7:90-94.
25.
Dorn F, Stehle S, Lockau H, Zimmer C, Liebig T: Endovascular treatment of acute intracerebral artery occlusions with the solitaire stent: single-centre experience with 108 recanalization procedures. Cerebrovasc Dis 2012;34:70-77.
26.
Kabbasch C, Mpotsaris A, Chang DH, Hiss S, Dorn F, Behme D, et al: Mechanical thrombectomy with the Trevo ProVue device in ischemic stroke patients: does improved visibility translate into a clinical benefit? J Neurointerv Surg 2016;8:778-782.
27.
Pfaff J, Herweh C, Pham M, Schonenberger S, Nagel S, Ringleb PA, et al: Mechanical thrombectomy in patients with acute ischemic stroke and lower NIHSS scores: recanalization rates, periprocedural complications, and clinical outcome. AJNR Am J Neuroradiol 2016, Epub ahead of print.
28.
Semelka RC, Ryan AF, Yonkers S, Braga L: Objective determination of standard of care: use of blind readings by external radiologists. AJR Am J Roentgenol 2010;195:429-431.
29.
Kallmes DF: TICI: if you are not confused, then you are not paying attention. Am J Neuroradiol 2012;33:975-976.
30.
Nguyen TN, Malisch T, Castonguay AC, Gupta R, Sun CH, Martin CO, et al: Balloon guide catheter improves revascularization and clinical outcomes with the Solitaire device: analysis of the North American solitaire acute stroke registry. Stroke 2014;45:141-145.
31.
Akins PT, Amar AP, Pakbaz RS, Fields JD; SWIFT Investigators: Complications of endovascular treatment for acute stroke in the SWIFT trial with solitaire and Merci devices. AJNR Am J Neuroradiol 2014;35:524-528.
32.
Dorn F, Prothmann S, Patzig M, Lockau H, Kabbasch C, Nikoubashman O, et al: Stent retriever thrombectomy in patients who are ineligible for intravenous thrombolysis: a multicenter retrospective observational study. AJNR Am J Neuroradiol 2016;37:305-310.
33.
Kim JS, Kim YJ, Ahn SH, Kim BJ: Location of cerebral atherosclerosis: Why is there a difference between East and West? Int J Stroke 2016;pii:1747493016647736.
34.
Santos EM, Marquering HA, den Blanken MD, Berkhemer OA, Boers AM, Yoo AJ, et al: Thrombus permeability is associated with improved functional outcome and recanalization in patients with ischemic stroke. Stroke 2016;47:732-741.
35.
Singer OC, Berkefeld J, Nolte CH, Bohner G, Haring HP, Trenkler J, et al: Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study. Ann Neurol 2015;77:415-424.
36.
Singer OC, Haring HP, Trenkler J, Nolte CH, Bohner G, Neumann-Haefelin T, et al: Periprocedural aspects in mechanical recanalization for acute stroke: data from the ENDOSTROKE registry. Neuroradiology 2013;55:1143-1151.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.